BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20374539)

  • 1. Correlations between Z-scores of VSRAD and regional cerebral blood flow of SPECT in patients with Alzheimer's disease and mild cognitive impairment.
    Li X; Shimizu S; Jibiki I; Watanabe K; Kubota T
    Psychiatry Clin Neurosci; 2010 Jun; 64(3):284-92. PubMed ID: 20374539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT.
    Hirao K; Ohnishi T; Hirata Y; Yamashita F; Mori T; Moriguchi Y; Matsuda H; Nemoto K; Imabayashi E; Yamada M; Iwamoto T; Arima K; Asada T
    Neuroimage; 2005 Dec; 28(4):1014-21. PubMed ID: 16129627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional cerebral blood flow assessed with 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease.
    Encinas M; De Juan R; Marcos A; Gil P; Barabash A; Fernández C; De Ugarte C; Cabranes JA
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1473-80. PubMed ID: 14579086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rate of progression of Alzheimer's disease in younger versus older patients: a longitudinal single photon emission computed tomography study.
    Sakai M; Hanyu H; Kume K; Sato T; Hirao K; Kanetaka H; Abe S; Kanaya K; Sakurai H; Iwamoto T
    Geriatr Gerontol Int; 2013 Jul; 13(3):555-62. PubMed ID: 22963387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of brain perfusion SPECT in Alzheimer's disease using a fully automated regional cerebral blood flow quantification software, 3DSRT.
    Kobayashi S; Tateno M; Utsumi K; Takahashi A; Saitoh M; Morii H; Fujii K; Teraoka M
    J Neurol Sci; 2008 Jan; 264(1-2):27-33. PubMed ID: 17764699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations between atrophy of the entorhinal cortex and cognitive function in patients with Alzheimer's disease and mild cognitive impairment.
    Li X; Jiao J; Shimizu S; Jibiki I; Watanabe K; Kubota T
    Psychiatry Clin Neurosci; 2012 Dec; 66(7):587-93. PubMed ID: 23252925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks.
    Varrone A; Pappatà S; Caracò C; Soricelli A; Milan G; Quarantelli M; Alfano B; Postiglione A; Salvatore M
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1447-54. PubMed ID: 12397463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trail making test B and brain perfusion imaging in mild cognitive impairment and mild Alzheimer's disease.
    Terada S; Sato S; Nagao S; Ikeda C; Shindo A; Hayashi S; Oshima E; Yokota O; Uchitomi Y
    Psychiatry Res; 2013 Sep; 213(3):249-55. PubMed ID: 23830931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relation of regional cerebral perfusion and atrophy in mild cognitive impairment (MCI) and early Alzheimer's dementia.
    Luckhaus C; Cohnen M; Flüss MO; Jänner M; Grass-Kapanke B; Teipel SJ; Grothe M; Hampel H; Peters O; Kornhuber J; Maier W; Supprian T; Gaebel W; Mödder U; Wittsack HJ
    Psychiatry Res; 2010 Jul; 183(1):44-51. PubMed ID: 20541374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristic deterioration of ADAS-Jcog subscale scores and correlations with regional cerebral blood flow reductions in Alzheimer's disease.
    Yoshii F; Kawaguchi C; Kohara S; Shimizu M; Onaka H; Ryo M; Takahashi W
    Neurol Sci; 2018 May; 39(5):909-918. PubMed ID: 29508099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (99m)Tc hexamethyl-propylene-aminoxime single-photon emission computed tomography prediction of conversion from mild cognitive impairment to Alzheimer disease.
    Devanand DP; Van Heertum RL; Kegeles LS; Liu X; Jin ZH; Pradhaban G; Rusinek H; Pratap M; Pelton GH; Prohovnik I; Stern Y; Mann JJ; Parsey R
    Am J Geriatr Psychiatry; 2010 Nov; 18(11):959-72. PubMed ID: 20808143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive and functional neuroimaging correlate for anosognosia in mild cognitive impairment and Alzheimer's disease.
    Vogel A; Hasselbalch SG; Gade A; Ziebell M; Waldemar G
    Int J Geriatr Psychiatry; 2005 Mar; 20(3):238-46. PubMed ID: 15717342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment.
    Habert MO; Horn JF; Sarazin M; Lotterie JA; Puel M; Onen F; Zanca M; Portet F; Touchon J; Verny M; Mahieux F; Giron A; Fertil B; Dubois B
    Neurobiol Aging; 2011 Jan; 32(1):15-23. PubMed ID: 19250707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain SPECT in subtypes of mild cognitive impairment. Findings from the DESCRIPA multicenter study.
    Nobili F; Frisoni GB; Portet F; Verhey F; Rodriguez G; Caroli A; Touchon J; Calvini P; Morbelli S; De Carli F; Guerra UP; Van de Pol LA; Visser PJ
    J Neurol; 2008 Sep; 255(9):1344-53. PubMed ID: 18958573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regional cerebral blood flow measured by three-dimensional stereotactic surface projections (3D-SSP) of 123I-IMP SPECT in Parkinson disease patients with cognitive impairment].
    Sakai T; Kuzuhara S
    Rinsho Shinkeigaku; 2003 Apr; 43(4):183-7. PubMed ID: 12884829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A region-of-interest template for three-dimensional stereotactic surface projection images: initial application to the analysis of Alzheimer's disease and mild cognitive impairment.
    Kubota T; Ushijima Y; Okuyama C; Nishimura T
    Nucl Med Commun; 2006 Jan; 27(1):37-44. PubMed ID: 16340722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.
    Johnson NA; Jahng GH; Weiner MW; Miller BL; Chui HC; Jagust WJ; Gorno-Tempini ML; Schuff N
    Radiology; 2005 Mar; 234(3):851-9. PubMed ID: 15734937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the regional cerebral blood flow changes during long-term donepezil therapy in patients with Alzheimer's disease using 3DSRT.
    Kimura N; Kumamoto T; Masuda T; Hanaoka T; Okazaki T; Arakawa R
    J Neuroimaging; 2012 Jul; 22(3):299-304. PubMed ID: 21699607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The progression of cognitive deterioration and regional cerebral blood flow patterns in Alzheimer's disease: a longitudinal SPECT study.
    Hanyu H; Sato T; Hirao K; Kanetaka H; Iwamoto T; Koizumi K
    J Neurol Sci; 2010 Mar; 290(1-2):96-101. PubMed ID: 19931870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parametric mapping of cerebral blood flow deficits in Alzheimer's disease: a SPECT study using HMPAO and image standardization technique.
    Imran MB; Kawashima R; Awata S; Sato K; Kinomura S; Ono S; Yoshioka S; Sato M; Fukuda H
    J Nucl Med; 1999 Feb; 40(2):244-9. PubMed ID: 10025830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.